Product image of Kabipac Glucosado En Cloruro De Sodio (Sodium Chloride, Glucose Monohydrate) supplied by GNH India

Kabipac Glucosado En Cloruro De Sodio

Active Ingredient:
Sodium Chloride, Glucose Monohydrate
Origin:
EU

Kabipac Glucosado En Cloruro De Sodio (Sodium Chloride, Glucose Monohydrate)

Sodium chloride and glucose monohydrate, the active ingredient in Kabipac Glucosado En Cloruro De Sodio, is an electrolyte solution presented as an injection solution for intravenous use. It helps restore extracellular fluid volume, correct electrolyte imbalances, and provide an energy substrate in patients requiring fluid and electrolyte replacement.

GNH India supplies Kabipac Glucosado En Cloruro De Sodio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and health‑care institutions worldwide.

Manufacturer / TM Owner

Fresenius Kabi España S.A.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kabipac Glucosado En Cloruro De Sodio is used in clinical situations that require rapid restoration of fluid and electrolyte balance.

  • Fluid and electrolyte replacement: restores intravascular volume and corrects sodium and glucose deficits.
  • Hypovolemia: increases circulating blood volume to improve tissue perfusion.
  • Hypoglycemia: supplies glucose to raise blood sugar levels in acute low‑glucose states.

How It Works

  • The solution delivers sodium chloride, which expands extracellular fluid by osmotically drawing water into the vascular compartment, and glucose monohydrate, which provides an immediate energy substrate and stimulates insulin release. Together they correct hyponatremia, support plasma osmolality, and replenish depleted energy stores, facilitating rapid re‑equilibration of fluid and electrolyte homeostasis.

Side Effects

Kabipac Glucosado En Cloruro De Sodio may be associated with the following adverse reactions.

Common Side Effects

  • Hypernatremia: elevated serum sodium levels due to excess sodium load.
  • Hyperglycemia: transient rise in blood glucose after infusion.
  • Phlebitis or pain at the infusion site.
  • Fluid overload: signs of edema or pulmonary congestion.
  • Electrolyte imbalance: shifts in potassium or chloride levels.

Serious or Rare Side Effects

  • Severe hypernatremia leading to neurological symptoms.
  • Anaphylactic reaction or severe hypersensitivity.
  • Pulmonary edema or acute heart failure in susceptible patients.

Precautions & Warnings

When using Kabipac Glucosado En Cloruro De Sodio, consider the following precautions.

  • Assess electrolyte status: obtain baseline sodium, chloride, and glucose values before infusion.
  • Monitor blood glucose: check glucose levels during and after administration, especially in diabetic patients.
  • Adjust infusion rate in cardiac or renal impairment: avoid rapid volume expansion.
  • Use aseptic technique: ensure sterile handling to prevent infection.
  • Avoid in patients with known hypersensitivity to sodium chloride or glucose solutions.
  • Store at 15-30°C: keep in original packaging, protect from light, and do not freeze.

Avoid Interactions

Kabipac Glucosado En Cloruro De Sodio can interact with other medicines as described below.

Major Interactions (Avoid)

  • Concurrent hypertonic saline or high‑dose sodium bicarbonate: risk of severe hypernatremia.
  • High‑dose insulin therapy: may cause rapid glucose shifts and hypoglycemia.

Moderate Interactions (Monitor Closely)

  • Loop or thiazide diuretics: may exacerbate electrolyte disturbances.
  • Antihypertensive agents: monitor blood pressure due to volume expansion.
  • Glycemic‑lowering drugs (e.g., metformin, sulfonylureas): watch for unexpected glucose fluctuations.
  • Renal replacement therapies: adjust dosing based on fluid balance needs.

Frequently Asked Questions

Kabipac Glucosado En Cloruro De Sodio is an intravenous electrolyte solution used to replace lost fluids, correct sodium and chloride deficits, and provide glucose for energy in patients with hypovolemia, electrolyte imbalance, or acute hypoglycemia.

The sodium chloride component expands extracellular fluid by osmotic water movement, restoring plasma volume and sodium balance. Glucose monohydrate supplies an immediate carbohydrate source, raises blood glucose, and stimulates insulin release, supporting cellular metabolism during fluid resuscitation.

The prescribed dose is determined by the treating clinician based on the patient’s fluid status, electrolyte levels, and clinical condition. Dosing is individualized and administered intravenously under medical supervision.

Safety data for use in pregnancy or lactation are limited. The product should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Kabipac Glucosado combines sodium chloride with glucose, offering both volume expansion and an energy substrate, whereas standard saline solutions provide only sodium and chloride. This dual composition can be advantageous in patients who need fluid resuscitation plus rapid glucose supplementation, such as those with hypoglycemia.

The product should be stored at controlled room temperature (15‑30 °C), protected from light, and kept in its original container. Do not freeze the solution, and avoid shaking vigorously to maintain solution integrity.

Kabipac Glucosado is administered intravenously by a qualified healthcare professional. The infusion rate is adjusted according to the patient’s clinical status, and the solution is typically delivered through a sterile IV line using standard infusion equipment.

Serious risks include severe hypernatremia, anaphylactic reactions, pulmonary edema, and acute heart failure in patients with compromised cardiac function. Prompt monitoring of electrolytes, fluid balance, and vital signs is essential to detect these complications early.

Patients with known hypersensitivity to sodium chloride, glucose, or any component of the formulation should avoid this product. It is also contraindicated in individuals with severe fluid overload, uncontrolled heart failure, or conditions where rapid sodium loading could be harmful.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Chloride, Glucose Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT